CellaVision DM Software Recall for LIS Data Transmission Malfunction
Cellavision AB is recalling CellaVision DM Software versions 6.0.1 and 6.0.2 due to a malfunction where cell comments are not sent to the Laboratory Information System.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score when no hospitalizations or serious injuries are reported. The hazard is a data transmission error rather than a direct physical injury risk.
Plain-English summary
Cellavision AB is recalling CellaVision DM Software versions 6.0.1 and 6.0.2 installed on CellaVision DM96, DM1200, DM9600, and DI-60 instruments. The recall involves 224 instruments and 99 software units in the United States, distributed nationwide in Florida, Illinois, New York, and North Carolina.
The recall is due to a software malfunction where White Blood Cell (WBC), Red Blood Cell (RBC), and Platelet (PLT) comments added after a slide is signed are not sent to the Laboratory Information System (LIS). This issue only occurs where customers process multiple slides per blood sample.
The devices are automated cell-locating instruments intended for use by skilled operators trained in blood cell recognition. No specific consumer action is detailed in the source text beyond the identification of the affected software versions and instruments.
The recalled product
- Product
- CellaVision DM Software versions 6.0.1 or 6.0.2 installed on the following products: CellaVision DM96, DM1200, DM9600 and DI-60 Product Usage: The devices are automated cell-locating devices. The devices automatically locates and presents images of blood cells on peripheral…
- Manufacturer
- Cellavision AB
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Versions 6.0.1 or 6.0.2
Distribution
Related recalls
Same manufacturer · Cellavision AB
See all →- HighCell morphology analyzers recalled over barcodes read from the previous slide
FDA (Devices) · 2025-11-26
Same hazard · data integrity
See all →- ModeratePhilips MR 7700 Software Upgrade Recalled for Incorrect DTI Data
FDA (Devices) · 2026-10-07
- ModeratePhilips Ingenia Blue Seal MRI Systems Recalled for DTI Export Errors
FDA (Devices) · 2026-10-07
- ModeratePhilips Ingenia Ambition MRI Systems Recalled for Incorrect DTI Data Exports
FDA (Devices) · 2026-10-07
- ModeratePhilips SmartPath to MR 7700 Recalled for Incorrect DTI Export Data
FDA (Devices) · 2026-10-07
- SevereVolcano Corp Recalls Philips IntraSight Plus Systems Due to Data Error
FDA (Devices) · 2026-10-07
Similar recalls
- HighCell morphology analyzers recalled over barcodes read from the previous slide
FDA (Devices) · 2025-11-26
- ModerateBioMérieux BacT/ALERT 3D 60 Recalled for Software Mislabeling Error
FDA (Devices) · 2012-11-28
- HighIllumina Worklist Manager Software Recalled for Performance Failure
FDA (Devices) · 2014-09-17
- HighMedical Imaging Software Recall: mint Lesion Orientation Display Malfunction
FDA (Devices) · 2024-12-25
- HighPhilips Brilliance 64 CT System Recalled for Software Defects
FDA (Devices) · 2015-12-16
- ModerateBioMérieux 3D B.40 Software Update Recalled for Patient Mislabeling
FDA (Devices) · 2012-11-28